Skip to content

OCULAR THERAPEUTIX, INC: filings

Every OCULAR THERAPEUTIX, INC annual and quarterly report in the SEC record with the published financial measures it tagged, 49 filings, each linked to its SEC index.

Filings with published measures

Each page shows what one filing reported, as tagged in that filing, with the periods it covered. Later filings can restate a value; the company overview shows the latest-filed value per period.

FormFiledFiscal periodMeasuresFactsSEC accession
10-Q2026-08-03fiscal Q2 2026391090001104659-26-089450
10-Q2026-05-05fiscal Q1 202639830001104659-26-055256
10-K2026-02-05fiscal FY 2025471200001104659-26-010664
10-Q2025-11-04fiscal Q3 2025401140001104659-25-105919
10-Q2025-08-05fiscal Q2 2025401100001558370-25-010177
10-Q2025-05-05fiscal Q1 202540850001558370-25-006225
10-K2025-03-03fiscal FY 2024491250001558370-25-002000
10-Q2024-11-14fiscal Q3 2024431190001558370-24-015613
10-Q2024-08-07fiscal Q2 2024421140001558370-24-011202
10-Q2024-05-07fiscal Q1 202442870001558370-24-007065
10-K2024-03-11fiscal FY 2023491270001558370-24-002902
10-Q2023-11-07fiscal Q3 2023431220001558370-23-017989
10-Q2023-08-07fiscal Q2 2023431160001558370-23-013591
10-Q2023-05-08fiscal Q1 202342880001558370-23-008510
10-K2023-03-06fiscal FY 2022491240001558370-23-002908
10-Q2022-11-07fiscal Q3 2022411170001558370-22-016610
10-Q2022-08-08fiscal Q2 2022411150001558370-22-012623
10-Q2022-05-09fiscal Q1 202241850001558370-22-007812
10-K2022-02-28fiscal FY 2021471230001558370-22-002363
10-Q2021-11-08fiscal Q3 2021401160001558370-21-015029
10-Q2021-08-09fiscal Q2 2021401110001558370-21-010967
10-Q2021-05-05fiscal Q1 202140840001558370-21-005914
10-K2021-03-11fiscal FY 202042860001558370-21-002813
10-Q2020-11-05fiscal Q3 2020401160001558370-20-012870
10-Q2020-08-07fiscal Q2 202034920001558370-20-009817
10-Q2020-05-08fiscal Q1 202040850001558370-20-005871
10-K2020-03-12fiscal FY 2019461490001558370-20-002537
10-Q2019-11-12fiscal Q3 2019431180001558370-19-010684
10-Q2019-08-07fiscal Q2 201937960001558370-19-007462
10-Q2019-05-10fiscal Q1 201942870001558370-19-004776
10-K2019-03-07fiscal FY 2018391280001558370-19-001659
10-Q2018-11-07fiscal Q3 201834880001558370-18-008793
10-Q2018-08-07fiscal Q2 201833860001558370-18-006598
10-Q2018-05-08fiscal Q1 201833700001558370-18-004317
10-K2018-03-08fiscal FY 2017371130001558370-18-001678
10-Q2017-11-07fiscal Q3 201737890001558370-17-008385
10-Q2017-08-08fiscal Q2 201732770001558370-17-006284
10-Q2017-05-05fiscal Q1 201728570001558370-17-003598
10-K2017-03-10fiscal FY 2016341130001558370-17-001627
10-Q2016-11-09fiscal Q3 201629770001193125-16-763691
10-Q2016-08-09fiscal Q2 201629750001193125-16-676019
10-Q2016-05-10fiscal Q1 201628570001193125-16-584714
10-K2016-03-10fiscal FY 2015351130001193125-16-499184
10-Q2015-11-10fiscal Q3 201532870001193125-15-373490
10-Q2015-08-10fiscal Q2 201532860001193125-15-284895
10-Q2015-05-15fiscal Q1 201529590001193125-15-188936
10-K2015-03-20fiscal FY 2014341070001193125-15-099288
10-Q2014-11-12fiscal Q3 201431800001193125-14-407860
10-Q2014-08-29fiscal Q2 201430770001193125-14-326864

Inspect the source

Entity
OCULAR THERAPEUTIX, INC / CIK 0001393434
Captured
2026-09-20T07:59:40.792Z
SEC response SHA-256
49208a819b449e933d340040d01c62c3d6db52e27de000c4850c8c33e540bcb2

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001393434.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))